Login / Signup

Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review.

Nima HajizadehAmirhossein HeidariSara SadeghiAzadeh Goodarzi
Published in: PloS one (2024)
Recent studies have recommended JAK and TNF inhibitors, especially oral tofacitinib and adalimumab, as a new modality or adjuvant therapy to previous medications for primary CA. Nonetheless, monitoring AEs on a regular basis is suggested, and further extensive studies are required before definitive recommendations.
Keyphrases
  • rheumatoid arthritis
  • case control
  • disease activity
  • ulcerative colitis
  • squamous cell carcinoma
  • systemic lupus erythematosus
  • combination therapy
  • protein kinase